ORMP ORAMED PHARMACEUTICALS INC Contract Awards 8-K Filing 2024 - Securities Agreement Oramed Pharmaceuticals entered into a Securities Purchase Agreement with Scilex, receiving a $101.9 million promissory note and warrants, and later refinanced part of this note, reducing its principal by $22.5 million, with $80.2 million repaid or refinanced in total.Get access to all SEC 8-K filings of the ORAMED PHARMACEUTICALS INC